跳至主要内容
临床试验/JPRN-UMIN000044693
JPRN-UMIN000044693招募中未知

Study of the renal protective effect of tolvaptan as a replacement of loop diuretics for the treatment of ascites in cirrhotic patients with renal dysfunction - Renal protective effect of tolvaptan for cirrhotic patients

Tohoku Medical and Pharmaceutical University0 个研究点目标入组 15 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with active infections, including spontaneous bacterial peritonitis 2. Patients with carcinomatous peritonitis 3. Patients with chronic kidney disease or heart failure 4. Patients with hepatocellular carcinoma or esophagogastric varices within 6 months of treatment 5. Patients receiving vasopressin antagonist 6. Women who are pregnant, potentially pregnant, within 28 days after delivery, or breast-feeding

研究者

相似试验

已完成
不适用
Renal protective effect of Samsca in patients with new-onset acute heart failureAcute heart failure
JPRN-UMIN000036417Kansai Medical University Medical Center122
已完成
不适用
The effect of tolvaptan on renal function during intensive treatment in patients with congestive heart failurecongestive heart failure
JPRN-UMIN000014134ishiarai Heart Center Hospital80
进行中(未招募)
1 期
The effects of tolvaptan on renal handeling of water and salt, hormones in the blood and the circulation, during blocking of the nitric oxide (NO) system in healthy subjects. A dose-response study.HyponatremiaSIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)MedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 100000004860
EUCTR2013-003800-38-DKDepartment of Medical Research22
招募中
1 期
Tolvaptan for nephrogenic diabetes insipidusephrogenic diabetes insipidusNephrogenic diabetes insipidus, polyuriaD018500
JPRN-jRCTs031180369Makita Noriko3
进行中(未招募)
1 期
Effects of the diuretic tolvaptan on nitric oxide systemSIADH (Syndrome of inappropriate ADH production)OverhydrationHyponatrimiaMedDRA version: 14.1Level: LLTClassification code 10021038Term: HyponatremiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: LLTClassification code 10040626Term: SIADHSystem Organ Class: 10014698 - Endocrine disorders
EUCTR2012-001169-33-DKDepartment of Medical Research20
Study of the renal protective effect of tolvaptan as... | 临床试验